10 studies found for:    "Autoimmune hemolytic anemia"
Show Display Options
RSS Create an RSS feed from your search for:
"Autoimmune hemolytic anemia"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Immunopathology of Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Anemia
Intervention: Biological: blood samples
2 Recruiting Rituximab in Auto-Immune Hemolytic Anemia
Condition: Warm Autoimmune Hemolytic Anemia
Interventions: Drug: rituximab  (Mabthera®);   Drug: Placebo
3 Completed Treatment of Autoimmune Thrombocytopenia (AITP)
Conditions: Autoimmune Disease;   Autoimmune Hemolytic Anemia;   Thrombocytopenia
Intervention: Device: Isolex 300i
4 Active, not recruiting Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.
Conditions: Anemia;   Anemia, Hemolytic;   Anemia, Hemolytic, Autoimmune;   Hemolysis;   Hematologic Diseases;   Autoimmune Diseases;   Immune System Diseases;   Pathologic Processes
Interventions: Drug: levamisole;   Drug: Prednisone
5 Completed A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Disease (Cold Type) (Warm Type)
Intervention: Drug: prednisone, low dose rituximab
6 Completed The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
Conditions: Pemphigus;   Auto-immune Thrombocytopenic Purpura;   Hemolytic Auto-immune Anaemia;   Cold Agglutinin Disease;   Cryoglobulinemia
Intervention: Drug: Rituximab (MABTHERA® or RITUXAN®).
7 Unknown  Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia That Did Not Respond to Fludarabine (Closed to Entry as of 10/2006), Chronic Lymphocytic Leukemia With Autoimmune Hemolytic Anemia, or Richter Transformation
Condition: Leukemia
Interventions: Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate
8 Completed Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia
Condition: Anemia, Hemolytic, Autoimmune
Interventions: Drug: prednisolone + mabthera;   Drug: Prednisolone
9 Completed Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
Conditions: Anemia, Hemolytic, Autoimmune;   Felty Syndrome;   Purpura, Thrombocytopenic;   Autoimmune Diseases
Interventions: Drug: cyclophosphamide;   Drug: filgrastim
10 Unknown  Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
Conditions: Purpura, Schoenlein-Henoch;   Graft Versus Host Disease;   Anemia, Hemolytic, Autoimmune;   Rheumatoid Arthritis;   Churg-Strauss Syndrome;   Hypersensitivity Vasculitis;   Wegener's Granulomatosis;   Systemic Lupus Erythematosus;   Giant Cell Arteritis;   Pure Red Cell Aplasia;   Juvenile Rheumatoid Arthritis;   Polyarteritis Nodosa;   Autoimmune Thrombocytopenic Purpura;   Takayasu Arteritis
Interventions: Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: filgrastim;   Drug: methylprednisolone;   Drug: prednisone;   Procedure: Autologous Peripheral Blood Stem Cell Transplantation

Indicates status has not been verified in more than two years